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Abstract
Objective: To test the reliability and validity of using the Borg rating of
perceived exertion (RPE) scale (ratings 6–20) in persons with multiple
sclerosis (PwMS).
Design: Nonrandomized repeated measures.
Setting: Research laboratory.
Participants: Volunteer sample (N=27) comprised of 16 PwMS (10 women)
and 11 age-matched persons without multiple sclerosis (MS) (6 women).
Clinical measures included symptomatic fatigue, depression, and MS
functional capacity.
Interventions: A submaximal cycling test was performed to estimate
maximal capacity. Participants then pedaled for 2 minutes at 50% and 60%
of predicted maximal oxygen consumption per unit time (V̇Ο2 ), and
physiological measures and RPE were obtained (week 1: response protocol).
One week later, participants replicated the prescribed V̇Ο2 using the RPE
range from week 1 (week 2: reproduction protocol). V̇ Ο2, heart rate, and
respiratory quotient were measured continuously; RPE and workload were
measured every minute; and blood lactate and mean arterial pressure were
measured after exercise.
Main Outcome Measures: RPE, workload, V̇Ο2 , and heart rate from week 1
to week 2.
Results: PwMS had greater fatigue (P<.01) and disability (P <.001).
Baseline measures were similar between groups and weeks. During exercise,
RPE, workload, (V̇Ο2 , and heart rate were similar between groups. Both
groups had an intraclass correlation coefficient >.86 for RPE, workload, and
V̇Ο2. The intraclass correlation coefficient was comparatively lower for heart
rate for both groups (MS group: .72, non-MS group: .83). RPE was highly
correlated with V̇Ο2 (r=.691, P<.001) and workload (r=.700, P<.001) for the
MS group.
Conclusions: Results suggest that RPE can be reliably reproduced, is valid,
and may be used in exercise prescription in mildly to moderately impaired
PwMS during cycling exercise.
Keywords: Exercise; Multiple sclerosis; Physical exertion; Rehabilitation
List of abbreviations








MAP, mean arterial pressure;
MS, multiple sclerosis;
MSFC, Multiple Sclerosis Functional Composite;
PwMS, persons with multiple sclerosis;
RPE, rating of perceived exertion;
RQ, respiratory quotient;
V̇Ο2, oxygen consumption per unit time

Multiple sclerosis (MS) is an autoimmune disease of the central
nervous system which often causes sensory, motor, and autonomic
impairment and leads to fatigue, weakness, and decreased physical
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activity.1, 2 and 3 Exercise for persons with multiple sclerosis (PwMS) was
once contraindicated.4 and 5 Now, evidence supports the use of exercise
in PwMS to improve muscle strength,6, 7 and 8 cardiorespiratory
function,9 and 10 quality of life,8, 9, 11 and 12 depression,9, 12 and 13 and
fatigue.9, 11 and 14 Therefore, it is important to develop safe and effective
exercise prescriptions and recommendations for PwMS.
Exercise intensity is a key component of exercise prescription15
and often is prescribed with a training heart rate range. In many
fitness settings, a submaximal aerobic test, if any at all, is used to
determine a training heart rate range.16 Submaximal tests rely on an
approximation of maximal heart rate, but alterations in cardiovascular
autonomic control in some PwMS may lead to error in heart rate
approximations.17, 18, 19 and 20 This may limit the use of heart rate as an
indicator of exercise intensity in some PwMS. In addition, heart rate
can be altered by factors including exercise mode, posture,
temperature, drugs, and anxiety.21 Many of these factors can be
altered in PwMS, which could limit the use of heart rate for exercise
prescription in PwMS.
Ratings of perceived exertion (RPEs) have been recommended
to monitor exercise intensity in PwMS.1, 22 and 23 The RPE is mediated by
physiological and psychological factors, performance settings, and
exertional symptoms.24 The RPE has been used successfully in many
populations24 and is endorsed for monitoring exercise intensity.15
Because the RPE is mediated by aspects of exercise in addition to
heart rate,24 it may overcome potential issues with using heart rate for
exercise prescription in PwMS or represent an alternative or
complementary approach.
Systematic (validity) and random error (reliability) of using the
RPE in PwMS may be affected by some of the same factors that might
make heart rate unsuitable for exercise prescription. Increased central
neural drive,25 and 26 symptomatic fatigue,4 and 27 depression,28 and
impaired sensory feedback29 or integration30 in PwMS may affect the
validity of using the RPE in this population. In addition, greater
variability exists in PwMS compared with people without MS for
depression,31 fatigue,27 information processing,32 and other factors that
could affect the RPE. This greater variability may affect the reliability
of the RPE in PwMS.
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Nevertheless, the RPE can be similar in PwMS and people
without MS during incremental dynamic exercise to task failure33 and
during submaximal isometric exercise.34 These earlier studies provide
initial validation of the RPE in PwMS. However, little is known about
the validity of the RPE during submaximal dynamic exercise, which is
typically prescribed for health and fitness. Importantly, it also is not
known if the RPE in PwMS is reproducible, which is necessary for
validity. If the physiological exercise-related processes associated with
the RPE are shown to be reliable and valid in PwMS during submaximal
aerobic exercise, then the RPE could be a valuable tool for exercise
prescription and monitoring.
Therefore, the purpose of this study was to test the reliability
and validity of the Borg RPE scale (ratings 6–20) during submaximal
aerobic exercise at a given exercise intensity in PwMS. To achieve
some degree of ecologic validity, we determined this exercise intensity
using standard techniques and estimated relative intensities that might
be used in a fitness setting.

Methods
Participants were tested over 2 visits separated by 6 to 10 days.
During the first visit, participants underwent a submaximal exercise
test, performed cycling at 50% and 60% of their predicted maximal
effort (response protocol), and practiced reproducing the associated
RPE (production protocol). During the second visit, participants
reproduced the effort from week 1 by matching the same RPE range
(reproduction protocol). Testing was performed at 50% to 60% of
maximal effort to provide flexibility in the exertion level but maintain
the ability to compare responses between weeks. Exercise was
performed on an electrically braked cycle ergometer (VIAsprint 150Pa)
at 60±3 revolutions per minute. Questionnaires and baseline
physiological measurements were collected prior to exercise each
week.

Participants
Participants were initially recruited through advertisements from
the Wisconsin chapter of the National Multiple Sclerosis Society. We
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also recruited participants who matched our inclusion criteria from a
pool of individuals from unrelated studies. All participants were
nonsmokers; had no other major neurologic, metabolic, or
cardiovascular diseases; did not use cardiovascular drugs (eg, betablockers); and were not in a concurrent clinical drug trial. Control
participants were recruited to have a similar mean age and sex
composition. All participants provided written informed consent,
approved by the Marquette University Institutional Review Board.
Sample size was determined to achieve precise estimates of reliability
(confidence interval width, 0.2), with an intraclass correlation
coefficient of 0.9.35

Questionnaires
Prior to exercise testing each week, participants completed
questionnaires to assess symptomatic fatigue and depressive
symptoms. Symptomatic fatigue was measured with the Modified
Fatigue Impact Scale,36, 37 and 38 and depressive symptoms were
measured with the Center for Epidemiologic Studies–Depression
Scale.39 and 40 Participants also reported recent caffeine consumption,
hours of sleep the prior night, and recent physical activity. PwMS
reported the last date of any disease-modifying therapy. For the
second visit, participants were instructed to replicate their levels of
caffeine consumption, sleep, and physical activity and maintain a
similar therapy regimen. No participants showed noticeable deviations
in these measures from week 1 to week 2.

Disability
All participants completed the Multiple Sclerosis Functional
Composite (MSFC), a measure of global function consisting of the
timed 25-foot walk, 9-hole peg test, and Paced Auditory Serial
Addition Task.41 and 42 Scores from each component were presented
individually and were transformed into a z score based on a
representative database of PwMS. 43
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Baseline measures
Prior to exercise, baseline measures were obtained with
participants seated on the cycle ergometer and included the following:
oxygen consumption per unit time (V̇Ο2 ) and respiratory quotient (RQ)
obtained continuously with open circuit spirometry (Vmax Encorea) and
calibrated prior to each experimental session; heart rate measured
from a heart rate monitor (Polar T31b); blood lactate obtained with a
finger prick (Lactate Proc); and brachial artery pressure measured by
manual sphygmomanometry. Blood pressure is presented as mean
arterial pressure (MAP) (diastolic pressure + [1/3 × pulse pressure]).
Participants were oriented to and taught how to use the Borg RPE
scale (ratings 6–20) as previously described.24 Orientation included
verbal and mental anchoring to the range of exertion on the scale.24

Submaximal test
Participants underwent a submaximal Young Men's Christian
Association test after performing a 3-minute warm-up at 25W.44
Maximal V̇Ο2 was predicted by linear extrapolation of
V̇Ο2 and heart rate to age-predicted maximal heart rate.15 Intensity
levels for exercise testing were determined as a percentage of
predicted maximal V̇Ο2 levels. V̇Ο2 and heart rate were measured
continuously, RPE and workload were measured every minute, and
blood pressure was obtained at the end of each stage. Each
submaximal test lasted approximately 10 minutes.

Response protocol
The RPE range associated with a range of exercise intensities
was determined. Participants rested after the submaximal test until
heart rate and MAP returned to baseline levels and then exercised at
50% and 60% of their predicted maximal V̇Ο2. Two minutes of cycling
was performed at each intensity level with no warm-up period.
Workloads were set by the investigators, and participants were blinded
to this workload. Participants provided RPEs twice for each workload
and were instructed to internalize the sensations associated with this
RPE range. V̇Ο2, heart rate, and RQ were continuously measured, and
the RPE and workload were recorded every minute. Blood pressure
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was obtained during the last minute of exercise, and lactate was
measured within 1 minute of the termination of exercise.

Production protocol
Next, participants practiced reproducing the effort level from the
response protocol to acquaint them with the procedure for the second
visit. Participants rested until heart rate and MAP recovered to baseline
and then pedaled for 4 minutes within the RPE range they experienced
during the response protocol.21 Blinding was performed, and initial
workload was randomly chosen to be 5 to 15W higher or lower than
the workload range from the response protocol. Participants were
instructed to adjust the resistance to maintain an effort that was
within the target RPE range and were encouraged to maintain the
desired effort. RPE, V̇Ο2, heart rate, RQ, lactate, and blood pressure
were all collected as during the response protocol.

Reproduction protocol
Then 6 to 10 days later, participants reproduced the effort level
from week 1. After a 3-minute warmup at approximately 25W,
participants pedaled for 4 minutes and reproduced the RPE range
associated with their training range (50%–60% of the estimated
maximal V̇Ο2) from the first visit. Blinding was again performed.
Participants were instructed to adjust the resistance to achieve this
RPE range. RPE, workload, V̇Ο2, heart rate, RQ, lactate, and blood
pressure were measured in the same manner as during week 1.

Analysis
Repeated-measures analysis of variance was used to compare
physiological measures obtained during exercise, resting physiological
variables, and questionnaire data from week 1 (response protocol)
with week 2 (reproduction protocol) for PwMS and the non-MS group.
Intraclass correlation coefficients model 2,1 were obtained to assess
the reliability of the RPEs and other physiological measures across
weeks.45 For the response and reproduction protocol, Pearson
correlations were performed between the RPE and measured
physiological variables as an indication of convergent validity. These
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correlations were then transformed to Fisher z scale, averaged, and
inverse transformed (average estimate). Student t tests were used to
compare subject characteristics, MSFC scores, and predicted maximal
values between the MS and non-MS groups. Data were analyzed using
SPSS Statistics 22.0. d Significance was accepted at P≤.05.

Results
Participant characteristics
Sixteen participants with MS (10 women; Expanded Disability
Status Scale score median, 1.75; range, 1–5) were compared with 11
participants without MS (6 women) (table 1). Disease courses for the
MS group were relapsing-remitting (n=9), progressive (n=5), and
unknown (n=2). The MS and non-MS groups were similar in age,
height, and mass. The MSFC z score was lower in the MS group
compared with the non-MS group. Correspondingly, the timed 25-foot
walk and 9-hole peg test were slower, and the Paced Auditory Serial
Addition Test score was lower in the MS group.
Table 1. Subject characteristics
Variables

MS Group

Non-MS Group

95% CI

P

Years since diagnosis

5.5 (1–20)

Age (y)

45.7±4.9

42.9±7.5

−2.1 to 7.7

.254

Mass (kg)

72.9±18.3

74.6±14.4

−15.3 to 12.0

.804

Height (m)

1.69±0.12

1.73±0.11

−0.13 to 0.06

.451

MSFC z score

0.27±0.53

1.01±0.26

−1.1 to −0.39

<.001∗

Timed 25-foot walk (s)

4.62±1.77

3.38±0.65

0.08 to 2.40

.037∗

9-hole peg test (s)

21.4±4.3

17.0±2.0

1.5 to 7.3

.004∗

PASAT

43.9±15.2

56.1±2.9

−20.4 to −3.9

.006∗

NOTE. Values are mean ± SD, mean (range), or as otherwise indicated.
Abbreviations: CI, confidence interval; PASAT, Paced Auditory Serial Addition Test.
∗P<.05.

Baseline measures
There were no group, time, or group×time effects for baseline
RPE, V̇Ο2, heart rate, RQ, lactate, and MAP (table 2). Baseline fatigue
was greater, and there was a trend for greater depression in the MS
group, but fatigue and depression levels were consistent between
weeks. Room temperature and humidity were not different between
weeks; however, room temperature was lower in the MS group.
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Table 2. Preexercise baseline variables
Variables

V̇Ο2 (L/min)
V̇Ο2 (mL/kg/min)
HR (beats/min)
MAP (mmHg)

Group
MS

Lactate (mmol/L)
CES-D

MS

3.9±0.9

4.5±1.6

Group

.83

Non-MS 4.0±0.9

4.2±1.2

Time

.14

MS

69.1±15.0 73.3±15.1 Group

Non-MS 74.7±12.0 76.5±6.5
MS

Time

.10

90.3±8.3

Group

.88

Non-MS 89.9±8.0

89.6±6.3

Time

.97
.50

MS

2.9±2.6

1.9±0.5

Group

.65

Non-MS 2.1±0.8

2.2±1.1

Time

.24

MS

8.5±10.0

Group

.06∗

2.7±3.0

Time

.49

Room humidity (%)

29.2±22.9 29.1±22.6 Group
3.9±5.2

Time

.86

MS

21.7±1.0

22.0±1.1

Group

.03†

Non-MS 22.9±1.9

22.9±1.8

Time

.37

36.8±11.5 33.4±11.6 Group

Non-MS 43.7±12.1 43.9±10.1 Time

.48
.88
.68
.21
.94

<.001†

Non-MS 4.2±6.3

MS

.37

.95

Non-MS 0.83±0.06 0.82±0.14 Time

7.7±10.0

.33

.38

90.1±7.5

0.84±0.09 0.82±0.12 Group

Interaction, P

.99
.16

MS

Room temperature (°C)

Main Effects, P

0.28±0.10 0.32±0.12 Group

Non-MS 2.1±2.0

MFIS

Week 2

Non-MS 0.30±0.08 0.31±0.08 Time

MS

RQ

Week 1

.95
.55

.06
.15

.11

NOTE. Values are mean ± SD or as otherwise indicated.
Abbreviations: CESD, Center for Epidemiologic Studies Depression Scale; HR, heart
rate; MFIS, Modified Fatigue Impact Scale.
∗Trend for significance.
†P<.05.

Submaximal test
The Young Men's Christian Association test produced similar predicted
maximal workload, V̇Ο2, and heart rate in the MS and non-MS groups
(table 3). The lack of difference between groups highlights that the MS
group was only mildly to moderately impaired.
Table 3. Predicted maximal levels
Variables

MS Group

Non-MS Group

95% CI

P

V̇Ο2 (mL/kg/min)

37.4±13.5

35.4±10.3

−7.9 to 11.9

.684

Workload

178.4±84.3

184.4±62.4

−67 to 56

.844

HR (beats/min)

174.3±4.91

177.1±7.5

−7.7 to 2.1

.254

NOTE. Values are mean ± SD or as otherwise indicated.
Abbreviations: CI, confidence interval; HR, heart rate.
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Exercise measurements
Repeated-measures analysis of variance indicated no group (MS
group vs non-MS group), time (week 1 vs week 2), or group×time
effects for RPE, workload, V̇Ο2, or MAP (fig 1). Heart rate decreased
from week 1 to week 2 (P=.015), but decreased similarly in both
groups. RQ increased in both groups from week 1 to week 2 (P<.001),
with a greater increase in the MS group (P=.008). All participants
remained within the prescribed target training range based on the RPE
during week 2 (reproduction protocol). Exercise physiological variables
were similar among different MS disease types (data not shown,
P>.05).

Fig 1. Responses to a prescribed RPE training range. Gray lines indicate individual
data, whereas black lines represent group averages. Values displayed in the figure are
average values for the indicated group. Abbreviation: HR, heart rate.
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RPE reliability
Table 4 indicates moderate to high reliability for key exercise
variables for both MS and non-MS groups. Heart rate showed
moderate reliability in both groups. In contrast, reliability for RQ and
lactate were comparatively weak for both groups. Bland-Altman plots
(fig 2) do not reveal any systematic biases. For RPE and other
physiological measures, the average difference value is near 0,
indicating reliable and agreeable measurements.
Table 4. ICCs between weeks 1 and 2
Variables

ICC

95% CI

P

MS group
RPE

.870

.668 to .953

<.001∗

Workload (W)

.862

.650 to .949

<.001∗

V̇Ο2 (L/min)
V̇Ο2 (mL/kg/min)

.925

.799 to .973

<.001∗

.850

.623 to .945

<.001∗

HR (bpm)

.716

.357 to .891

.001∗

RQ

.555

.100 to .818

.010∗

Lactate (mmol/L)

.521

.052 to .802

.016∗

MAP (mmHg)

.842

.577 to .946

<.001∗

Non-MS group
RPE

.938

.788 to .983

<.001∗

Workload (W)

.962

.865 to .990

<.001∗

V̇Ο2 (L/min)
V̇Ο2 (mL/kg/min)

.970

.894 to .992

<.001∗

.954

.839 to .987

<.001∗

HR (bpm)

.827

.481 to .950

<.001∗

RQ

.754

.314 to .927

.001∗

Lactate (mmol/L)

.205

−.421 to .699

.261

MAP (mmHg)

.871

.592 to .964

<.001∗

Abbreviations: bpm, beats per minute; CI, confidence interval; HR, heart rate; ICC,
intraclass correlation coefficient.
∗P<.05.
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Fig 2. Bland-Altman plots of differences in RPE and exercise responses between week
1 and week 2. The solid dashed line represents the average difference value, whereas
the top and bottom dashed lines represent 2 SD above and below the mean difference
value, respectively. Triangles represent individual participants with MS, and the circles
represent participants without MS. Abbreviation: HR, heart rate.

Convergent validity
Table 5 demonstrates that high correlations (convergent
validity) were found between the RPE and workload and V˙o2 for
both the MS and non-MS groups (criterion validity). In the non-MS
group, the RPE also showed high correlations with RQ and MAP.
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Table 5. Pearson correlations between physiological variables and RPE
Variables

Correlation With RPE
Week 1

Week 2

Average Estimate

MS group
Workload (W)

.720∗

.674∗

.700

V̇Ο2 (L/min)

.723∗

.660∗

.691

V̇Ο2 (mL/kg/min)

.476

.536∗

.507

HR (bpm)

−.336

−.225

−.282

RQ

.069

−.048

.019

Lactate (mmol/L)

−.476

.174

−.168

MAP (mmHg)

.121

.303

.211

Non-MS group
Workload (W)

.596

.558

.581

V̇Ο2 (L/min)

.642∗

.575

.613

V̇Ο2 (mL/kg/min)

.608∗

.506

.566

HR (bpm)

−.379

−.058

−.219

RQ

.405

.562

.476

Lactate (mmol/L)

.235

−.012

.114

MAP (mmHg)

.789∗

.627∗

.717

Abbreviations: bpm, beats per minute; HR, heart rate.
∗P<.05 for within-week correlations.

Discussion
To our knowledge, this study demonstrates for the first time
that the Borg RPE scale (ratings 6–20) is reliable over 1 week in
persons with mild to moderate MS during submaximal cycling exercise.
RPE, workload, V̇Ο2, and MAP were all similar between weeks 1 and 2.
Furthermore, these variables all had high intraclass correlations,
suggesting that individual participants had similar RPEs (and other
physiological measures) between weeks. Taken together, this suggests
that key indicators of exercise intensity, including the RPE, were
reproducible across 1 week.
This study also provides additional insight into the construct
validity of the RPE in PwMS. The high positive correlations in PwMS
between the RPE, V̇Ο2, and workload are what would be expected if the
RPE was linear and perceptually mediated by V̇Ο2 and workload, as in
persons without MS.34 That heart rate correlated poorly with the RPE is
consistent with heart rate being a mediating but not primary factor in
determining the perceptual response to effort.24 Blood lactate also
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poorly correlated with the RPE, but it is not thought to be linear with
the RPE until concentrations are above the lactate threshold. The low
mean RPE suggests that lactate concentrations were below this
threshold.24 The low correlation between the RPE and MAP in the MS
group may reflect issues with cardiovascular autonomic control17, 18, 19,
20 and 24
and confirms that MAP is not a primary mediator of the RPE.24
Finally, PwMS may have had saturated RQ values, resulting in a low
correlation with the RPE.
This study extends the findings of Morrison et al,33 which
demonstrated that the RPE is similar between persons with mild MS
and people without MS during incremental cycling exercise. A similar
result has been shown during sustained submaximal isometric
contractions.34 In contrast, Thickbroom et al26 showed an exaggerated
RPE in PwMS during isometric exercise compared with a non-MS
group. Our findings may differ because Thickbroom had participants
perform intermittent isometric contractions with a hand muscle,
whereas our study used a lower-limb cycling protocol.26 In this
previous study, PwMS had a faster rate of increase in the RPE, but
experienced similar relative muscle fatigue as people without MS.
Therefore, PwMS may be less accurate when estimating exertion for a
small muscle group. Overall, the literature appears to support the
validity of the RPE in PwMS, at least during cycling exercise. By
demonstrating reliability and further contributing to the validity of the
RPE, we provide credible evidence for recommendations to use the RPE
to monitor exercise intensity during aerobic exercise in PwMS.1, 22 and 23
Caution has been advised in using heart rate for exercise
prescription in PwMS because potential cardiovascular autonomic
impairment may lead to a blunted cardiovascular response46 and 47;
however, this is controversial.34 Our results do not necessarily support
this concern because heart rate–based measures, including response
to exercise, were similar in MS and non-MS groups. However, our
results do not preclude individual altered cardiovascular regulation in
PwMS as has been reported,17, 18, 19, 20, 34 and 48 and individual
assessment should take precedence in any exercise setting.
A submaximal exercise test was used as an initial method to
determine exercise intensities and simulate an exercise prescription
that might be encountered in a community health, fitness, or wellness
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setting.15 and 16 Although submaximal exercise tests have limitations,
the primary aim of this study was to determine whether a prescribed
exercise response associated with a RPE is reproducible and valid
based on the RPE. All measured values were within recommended
levels for exercise in PwMS, including the RPE (12.5).15 and 23
Fatigue, depression, and disease status were stable across test
sessions. Therefore, the validity of the RPEs in PwMS during a relapse
or otherwise nonstable phase of disease cannot be determined from
this study. One potential advantage of using the RPE to monitor
exercise intensity in a symptom-limited population is that the RPE is
independent of absolute work level and can be adjusted relative to
physiological state (eg, disease, sickness, environment). For example,
under symptom exacerbation, the absolute exercise workload may be
appropriately lower at a similar target RPE. It is important that the use
of the RPE under nonstable conditions be described systematically in
future studies.

Study limitations
The small number of participants in our study suggests that our
results should be considered of a pilot nature and interpreted with
care. As discussed, some have suggested that caution must be taken
when using submaximal data for predicting maximal V̇Ο2.46 Therefore,
a limitation is that we did not perform maximal V̇Ο2 tests; however,
predicted values were consistent with what others have observed.46
More importantly, the actual V̇Ο2 for the 2 exercise sessions was
reproducible and similar between groups. The room temperature for
PwMS was lower compared with people without MS. This difference in
temperature likely did not affect the reliability of the RPE because
temperature was similar between weeks for each group. All PwMS
tested were ambulatory and mildly to moderately impaired.
Consequently, our results should not be extrapolated to those who are
more seriously impaired. Finally, we do not know if our results can be
extrapolated to different exercise intensities, durations, or modes.
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Conclusions
These preliminary findings indicate that the Borg scale (ratings
6–20) can be reproducible over a week and are valid in persons with
mild to moderate MS. Therefore, the RPE may be a reliable and valid
method of monitoring and prescribing exercise intensity in PwMS
during cycling exercise. Exercise recommendations in an MS
population must be based on individual responses. Further
investigation is needed in this important area of exercise prescription
in PwMS.
Suppliers
a.
b.
c.
d.

BD.
Polar T31; Polar Electro.
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